Hinge Health Shares Surge 10% Post-Earnings: Q2 Revenue Jumps 55%, Forecasts Beat Expectations

In an upward trajectory post-market close on Tuesday, Hinge Health’s shares surged by 10%. This surge follows the digital physical therapy company’s initial quarterly report since its May debut on the New York Stock Exchange.

A comparison of the company’s Q2 results against analyst predictions, compiled by LSEG, reveals the following:

– Revenue for Hinge Health increased by 55% in Q2, reaching $138 million compared to $89.8 million during the corresponding period of the previous year.
– The company reported a net loss of $575.65 million, translating to a loss of $13.10 per share. In contrast, the same period last year recorded a loss of $12.93 million, equivalent to a loss of 96 cents per share. The GAAP loss from operations was reported as $580.7 million, with $591.0 million attributed to stock-based compensation expenses.

In an interview with CNBC on Tuesday, Hinge Health CEO Daniel Perez expressed optimism about the long-term potential of using software and connected hardware for automated care delivery. He emphasized that the company is still in the process of introducing itself to the world.

Founded in 2014, Hinge Health leverages software to assist patients in treating acute musculoskeletal injuries, managing chronic pain, and post-surgical rehabilitation remotely.

For Q3, Hinge anticipates reporting revenue between $141 million and $143 million. This prediction surpasses the $129 million expected by LSEG analysts.

For the entire year, the company forecasts a revenue of $548 million to $552 million, exceeding the $511 million anticipated by LSEG analysts.

On its debut in May, Hinge’s stock opened at $39.25, marking a 23% increase from its $32 IPO price. The shares closed at $48.22 on Tuesday.

During the company’s Q2 call with investors, Perez asserted, “We believe we’re fundamentally reshaping how care can be delivered more effectively and efficiently.”